Lucentis and Scar - a phase IV clinical study of FDA data
Summary:
Scar is reported as a side effect among people who take Lucentis (ranibizumab), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Avastin, and have Choroidal neovascularisation.
The phase IV clinical study analyzes which people have Scar when taking Lucentis. It is created by eHealthMe based on reports of 25,577 people who have side effects when taking Lucentis from the FDA, and is updated regularly.
What is Lucentis?
Lucentis has active ingredients of ranibizumab. It is often used in macular degeneration. eHealthMe is studying from 25,647 Lucentis users. Check the latest studies of Lucentis.
What is Scar?
Scar is found to be associated with 1,294 drugs and 1,415 conditions by eHealthMe. Check the latest studies of Scar.
25,577 people reported to have side effects when taking Lucentis.
Among them, 62 people (0.24%) have Scar.
Among these 62 people:
How long have people been on Lucentis when they have Scar? *
What is the gender of people who have Scar when taking Lucentis? *
What is the age of people who have Scar when taking Lucentis? *
What are other drugs people take besides Lucentis? *
What are other side effects people have besides Scar? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Lucentis and have Scar?
- Check whether Scar is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Lucentis:
- Lucentis (25,647 reports)
Scar treatments and more:
- Scar (24,198 reports)
How severe was Scar and when was it recovered:
Expand to all the drugs that have ingredients of ranibizumab:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Common Lucentis side effects:
- Lucentis side effect: Visual acuity reduced (reduced clearness of vision) (2,990 reports)
- Lucentis side effect: Visual impairment (1,629 reports)
- Lucentis side effect: Drug ineffective (1,173 reports)
- Lucentis side effect: Vision blurred (1,118 reports)
- Lucentis side effect: Eye haemorrhage (bleeding in the eye) (1,083 reports)
Browse all side effects of Lucentis:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon drugs associated with Scar:
- Humira side effect: Scar (1,648 reports)
- Adapalene side effect: Scar (1,573 reports)
- Prednisone side effect: Scar (1,394 reports)
- Aspirin side effect: Scar (1,102 reports)
- Magnevist side effect: Scar (1,032 reports)
- Omniscan side effect: Scar (848 reports)
- Methotrexate side effect: Scar (837 reports)
- Optimark side effect: Scar (757 reports)
- Enbrel side effect: Scar (721 reports)
- Lisinopril side effect: Scar (716 reports)
Browse all the drugs that are associated with Scar:
- Scar (1,294 drugs)
Common conditions associated with Scar:
- Acne: 1,424 reports
- Zits: 1,414 reports
- Ra: 1,242 reports
- Ms: 1,214 reports
- Contraception: 1,125 reports
- Pregnancy: 1,114 reports
- Pain: 947 reports
- Crohn's disease: 840 reports
- Psoriasis: 816 reports
- Nuclear magnetic resonance imaging abnormal: 809 reports
Browse all the conditions that are associated with Scar:
- Scar (1,415 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on ranibizumab (the active ingredients of Lucentis) and Lucentis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Mycophenolate Mofetil and Nose Bleed for Men aged 40-49 - 3 seconds ago
- Mycophenolate Mofetil and Nose Bleeds for Men aged 40-49 - 4 seconds ago
- Mycophenolate Mofetil and Nosebleeds for Men aged 40-49 - 4 seconds ago
- Mycophenolate Mofetil and Epistaxis for Men aged 40-49 - 5 seconds ago
- Mycophenolate Mofetil and Bleeding From The Nose for Men aged 40-49 - 5 seconds ago
- Drug interactions of Tramadol Hydrochloride and Ammonium Lactate - 5 seconds ago
- Mycophenolate Mofetil and Nosebleed for Men aged 40-49 - 6 seconds ago
- Fragmin and Dyspnoea for Women aged 40-49 - 15 seconds ago
- Fragmin and Dyspnea for Women aged 40-49 - 16 seconds ago
- Drug interactions of Ventolin Hfa and Risperdal - 19 seconds ago